COLLABORATION AND EXCLUSIVE LICENSE AGREEMENTCollaboration and Exclusive License Agreement • November 5th, 2009 • Transgenomic Inc • Laboratory analytical instruments • Nebraska
Contract Type FiledNovember 5th, 2009 Company Industry JurisdictionThis Collaboration and Exclusive License Agreement, dated as of January 23, 2009 (this “Agreement”), is entered into between Transgenomic, Inc., a Delaware corporation (“Transgenomic”), and Power3 Medical Products, Inc., a New York corporation (“Power3”).
LICENSE AGREEMENTLicense Agreement • November 5th, 2009 • Transgenomic Inc • Laboratory analytical instruments • Massachusetts
Contract Type FiledNovember 5th, 2009 Company Industry JurisdictionThis agreement, effective as of October 1st, 2009 (“Effective Date”), is between the Dana-Farber Cancer Institute, Inc., a Massachusetts non-profit organization having a principal place of business at 44 Binney Street, Boston, Massachusetts, 02115 (“DFCI”) and Transgenomic, Inc., a Delaware corporation having a principal place of business at 12325 Emmet Street, Omaha, Nebraska 68164 (“Licensee”).